NDC codes

FDA NDC Directory
Product NDC (as listed)87063-299Labeler and product segments. Claims need a package NDC.
Product NDC at billing width87063-0299Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
87063-299-108706302991010 SYRINGE, GLASS in 1 CARTON (87063-299-10) / .5 mL in 1 SYRINGE, GLASS (87063-299-01)Marketed from Jul 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Flucelvax
Generic name (nonproprietary)
influenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated)
Active ingredients
Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) — 15 ug/.5mLInfluenza a virus a/tasmania/787/2025 cvr-388 (H3n2) antigen (Mdck cell derived, Propiolactone inactivated) — 15 ug/.5mLInfluenza b virus - b/arizona/21/2025 antigen (Mdck cell derived, Propiolactone inactivated) — 15 ug/.5mL
Dosage form
Injection, Suspension
Route
Intramuscular
Product type
Vaccine
Marketing category
BLA — Biologics License ApplicationApplication BLA 125408
Marketing start
Marketing end
Identifiers
Product ID 87063-299_5a564edc-83a3-1611-e063-6294a90a0b80SPL ID 5a564edc-83a3-1611-e063-6294a90a0b80

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N487063029910 followed by a unit qualifier and the quantity

Package 87063-0299-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125408

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125408
ProductStrengthForm · routeLabelerProduct NDC
Flucelvaxinfluenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated)Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredientsInjection, SuspensionIntramuscularSportpharm LLC85766-263
Flucelvaxinfluenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated)Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredientsInjection, SuspensionIntramuscularSeqirus Inc.70461-656
Flucelvaxinfluenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/victoria/800/2024 cvr-289 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/wuh4618/2021 antigen (mdck cell derived, propiolactone inactivated)Influenza a virus a/georgia/12/2022 cvr-167 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredientsInjection, SuspensionIntramuscularBamboo US BidCo LLC83703-088

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in